- Browse by Subject
Browsing by Subject "Prostate tumors"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target(Oxford University Press, 2021-01-27) Greulich, Benjamin M.; Plotnik, Joshua P.; Jerde, Travis J.; Hollenhorst, Peter C.; Pharmacology and Toxicology, School of MedicineThe TMPRSS2-ERG gene fusion and subsequent overexpression of the ERG transcription factor occurs in ∼50% of prostate tumors, making it the most common abnormality of the prostate cancer genome. While ERG has been shown to drive tumor progression and cancer-related phenotypes, as a transcription factor it is difficult to target therapeutically. Using a genetic screen, we identified the toll-like receptor 4 (TLR4) signaling pathway as important for ERG function in prostate cells. Our data confirm previous reports that ERG can transcriptionally activate TLR4 gene expression; however, using a constitutively active ERG mutant, we demonstrate that the critical function of TLR4 signaling is upstream, promoting ERG phosphorylation at serine 96 and ERG transcriptional activation. The TLR4 inhibitor, TAK-242, attenuated ERG-mediated migration, clonogenic survival, target gene activation and tumor growth. Together these data indicate a mechanistic basis for inhibition of TLR4 signaling as a treatment for ERG-positive prostate cancer.